| Literature DB >> 32443772 |
Timotheus B Darikwa1, Samuel O Manda2,3,4.
Abstract
Background: Cardiovascular diseases (CVDs) are part of the leading causes of mortality and morbidity in developing countries, including South Africa, where they are a major public health issue. Understanding the joint spatial clustering of CVDs and associated risk factors to determine areas in need of enhanced integrated interventions would help develop targeted, cost-effective and productive mediations. We estimated joint spatial associations and clustering patterns of 2 CVDs (stroke and heart attack) and 3 risk factors (hypertension, high blood cholesterol (HBC) and smoking) among adults in South Africa.Entities:
Keywords: South Africa; bivariate spatial autocorrelation; cardiovascular diseases; cluster; heart attack; high cholesterol; hypertension; prevalence; smoking; stroke
Year: 2020 PMID: 32443772 PMCID: PMC7277617 DOI: 10.3390/ijerph17103583
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The South African map showing the district names and sample sizes: South African Demographic and Health Survey, 2016.
Summary statistics of the prevalence of cardiovascular diseases (CVDs) and related risk factors across the districts.
| Sub-Group | CVD or Risk Factor | Minimum | 25% Quartile | Median | Mean | 75% Quartile | Max | Sample Size |
|---|---|---|---|---|---|---|---|---|
| All | Stroke | 0.0% | 0.0% | 1.1% | 1.2% | 1.6% | 9.1% | 9154 |
| Heart attack | 0.0% | 1.1% | 2.2% | 2.4% | 3.5% | 9.1% | ||
| Smoking | 0.0% | 15.8% | 20.8% | 21.9% | 25.0% | 53.2% | ||
| HBC | 0.0% | 0.7% | 1.5% | 2.2% | 3.0% | 9.1% | ||
| Hypertension | 9.5% | 27.6% | 32.9% | 34.3% | 41.2% | 65.4% | ||
| Male | Stroke | 0.0% | 0.0% | 0.0% | 1.1% | 1.2% | 20.0% | 3817 |
| Heart attack | 0.0% | 0.0% | 1.1% | 1.8% | 2.2% | 20.0% | ||
| Smoking | 0.0% | 31.8% | 37.8% | 39.0% | 46.1% | 81.8% | ||
| HBC | 0.0% | 0.0% | 0.7% | 1.8% | 2.9% | 20.0% | ||
| Hypertension | 0.0% | 22.4% | 29.6% | 31.2% | 40.8% | 80.0% | ||
| Female | Stroke | 0.0% | 0.0% | 1.3% | 1.3% | 2.2% | 5.4% | 5337 |
| Heart attack | 0.0% | 1.1% | 2.6% | 2.8% | 4.1% | 10.7% | ||
| Smoking | 0.0% | 1.7% | 4.8% | 9.9% | 12.3% | 41.7% | ||
| HBC | 0.0% | 0.2% | 1.6% | 2.4% | 2.9% | 12.5% | ||
| Hypertension | 15.4% | 29.9% | 35.7% | 36.3% | 41.6% | 66.7% | ||
| 15–39 | Stroke | 0.0% | 0.0% | 0.0% | 0.5% | 0.8% | 2.9% | 5848 |
| Heart attack | 0.0% | 0.0% | 0.3% | 0.9% | 1.4% | 4.6% | ||
| Smoking | 0.0% | 14.4% | 19.6% | 20.1% | 23.4% | 46.6% | ||
| HBC | 0.0% | 0.0% | 0.0% | 0.6% | 0.8% | 5.7% | ||
| Hypertension | 0.0% | 15.3% | 20.8% | 21.0% | 27.6% | 40.9% | ||
| 40–64 | Stroke | 0.0% | 0.0% | 1.5% | 2.2% | 3.5% | 10.0% | 3306 |
| Heart attack | 0.0% | 0.6% | 4.5% | 4.5% | 6.5% | 14.1% | ||
| Smoking | 0.0% | 15.7% | 21.8% | 23.4% | 29.6% | 66.7% | ||
| HBC | 0.0% | 1.3% | 3.3% | 4.6% | 5.7% | 19.1% | ||
| Hypertension | 25.0% | 47.2% | 56.8% | 55.5% | 63.9% | 92.3% | ||
| Male 15–39 | Stroke | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 2.0% | 2574 |
| Heart attack | 0.0% | 0.0% | 0.0% | 0.7% | 1.3% | 5.6% | ||
| Smoking | 0.0% | 27.4% | 35.7% | 35.4% | 44.5% | 66.7% | ||
| HBC | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% | 5.9% | ||
| Hypertension | 0.0% | 15.2% | 21.2% | 22.2% | 29.7% | 50.0% | ||
| Female 15–39 | Stroke | 0.0% | 0.0% | 0.0% | 0.7% | 1.3% | 4.4% | 3274 |
| Heart attack | 0.0% | 0.0% | 0.0% | 1.1% | 1.9% | 7.3% | ||
| Smoking | 0.0% | 1.2% | 3.9% | 8.0% | 7.9% | 40.5% | ||
| HBC | 0.0% | 0.0% | 0.0% | 0.8% | 1.1% | 10.3% | ||
| HT | 0.0% | 15.2% | 20.9% | 19.8% | 25.4% | 37.7% | ||
| Male 40–64 | Stroke | 0.0% | 0.0% | 1.2% | 2.1% | 2.5% | 25.0% | 1243 |
| Heart attack | 0.0% | 0.0% | 0.0% | 3.3% | 5.9% | 25.0% | ||
| Smoking | 0.0% | 35.0% | 42.9% | 45.2% | 52.1% | 100.0% | ||
| HBC | 0.0% | 0.0% | 0.0% | 3.7% | 5.7% | 25.0% | ||
| Hypertension | 0.0% | 36.5% | 50.0% | 46.9% | 61.3% | 100.0% | ||
| Female 40–64 | Stroke | 0.0% | 0.0% | 1.2% | 2.1% | 4.7% | 8.3% | 2063 |
| Heart attack | 0.0% | 0.0% | 4.9% | 5.1% | 7.6% | 18.8% | ||
| Smoking | 0.0% | 0.8% | 6.9% | 11.5% | 17.1% | 46.2% | ||
| HBC | 0.0% | 0.0% | 3.1% | 4.9% | 5.3% | 27.8% | ||
| Hypertension | 33.3% | 52.1% | 61.4% | 60.3% | 67.6% | 100.0% |
Figure A1Correlations between CVDs and their risk factors.
Figure 2Maps of the district prevalence rates of the CVDs and their related risk factors.
Figure 3Maps of the district standardized incidence rates of the CVDs and their related risk factors.
Effects of stratification on the sample size used in the analysis.
| Sub-Group | Mean | Std Error | Median | Minimum | Maximum | Range | Sample Size |
|---|---|---|---|---|---|---|---|
| All | 203 | 20 | 185 | 23 | 544 | 544 | 10,336 |
| All (15-64 years) | 179 | 18 | 157 | 11 | 503 | 492 | 9154 |
| Male (15-64 years) | 75 | 8 | 58 | 5 | 252 | 247 | 3817 |
| Female (15-64 years) | 105 | 10 | 89 | 6 | 288 | 282 | 5337 |
| Male 15-39 | 50 | 5 | 42 | 1 | 159 | 158 | 2574 |
| Female 15-39 | 64 | 6 | 55 | 1 | 193 | 192 | 3275 |
| Male 40-64 | 24 | 3 | 20 | 1 | 93 | 92 | 1243 |
| Female 40-64 | 40 | 4 | 36 | 3 | 125 | 122 | 2063 |
Global univariate and bivariate spatial autocorrelation association between the age–sex standardised incidence rates of CVDs and identified risk factors for all participants.
| Stroke | Heart Attack | Smoking | HBC | Hypertension | |
|---|---|---|---|---|---|
| Stroke | 0.128 * | −0.019 INS | 0.218 ** | 0.184 ** | −0.075 INS |
| Heart attack | −0.015 INS | −0.099 INS | −0.021 INS | −0.008 INS | |
| Smoking | 0.606 *** | 0.366 *** | 0.149 * | ||
| HBC | 0.355 *** | −0.077 INS | |||
| Hypertension | 0.236 ** |
Key: HBC, high cholesterol; HT, hypertension; INS, insignificant at 5% level; *, significant at 10% level; **, significant at 5% level; ***, significant at 1% level. Shaded elements are univariate global Moran’s indexes.
Figure A3Spatial Clusters of Prevalence of five CVDs and their risk factors.
Figure A2Univariate LISA cluster for the standardized incidence ratios of stroke, heart attack, hypertension, high blood cholesterol and Smoking.
Figure 4Joint spatial clusters of CVDs and their risk factors with significant association for all participants, adjusted for the national age-sex distribution of the sample.